DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Pyridoxal is an investigational drug.
There have been 9 clinical trials for Pyridoxal. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2001.
The most common disease conditions in clinical trials are Reperfusion Injury, Movement Disorders, and Myocardial Ischemia. The leading clinical trial sponsors are Medicure, University of Alabama at Birmingham, and Beersheva Mental Health Center.
Recent Clinical Trials for Pyridoxal
|Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria||Icahn School of Medicine at Mount Sinai||N/A|
|Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||N/A|
|Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria||University of Alabama at Birmingham||N/A|